xiao jun yao
Macau University of Science and Technology
Taipa, China
Review Editor
Anti-Cancer Drugs
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
nageswari yarravarapu
University of Texas Southwestern Medical Center
Dallas, United States
Review Editor
Anti-Cancer Drugs
fei ye
Harvard Medical School
Boston, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
cui-yun yu
University of South China
Hengyang, China
Review Editor
Anti-Cancer Drugs
kai yu
Arcus Biosciences
Hayward, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
peng zhan
Shandong University
Jinan, China
Review Editor
Technologies and Strategies to Enable Drug Discovery
johannes zeller
Baker Heart and Diabetes Institute
Melbourne, Australia
Review Editor
Anti-inflammatory and Immunomodulating Agents
dake zhang
Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University
Beijing, China
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
hongyuan zhang
The University of Manchester
Manchester, United Kingdom
Review Editor
Cardiovascular and Hematologic Drugs
jian zhang
Shanghai Jiao Tong University
Shanghai, China
Review Editor
Anti-Cancer Drugs
si zhang
Fudan University
Shanghai, China
Review Editor
Anti-inflammatory and Immunomodulating Agents
xiaonan zhang
Uppsala University
Uppsala, Sweden
Review Editor
Anti-Cancer Drugs
yang zhang
Hebei Medical University
Shijiazhuang, China
Review Editor
Anti-Infective Agents
yi-chao zheng
Zhengzhou University
Zhengzhou, China
Review Editor
Anti-Cancer Drugs
you-guang zheng
School of Pharmacy, Xuzhou Medical University
Xuzhou, China
Review Editor
Technologies and Strategies to Enable Drug Discovery
you zhou
Cardiff University
Cardiff, United Kingdom
Review Editor
Anti-inflammatory and Immunomodulating Agents